Hidemi Goto

机构：University of Oxford, Meijo Hospital, MRC Population Health Research Unit, Federation of National Public Service Personnel Mutual Aid Associations, Nagoya University · ORCID：0000-0001-8389-1416

发表论文 955 篇 · 总被引 18855 次 · h-index 71

代表论文

• Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial (2023 · The Lancet Diabetes & Endocrinology · 被引 122)
• Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial (2023 · The Lancet Diabetes & Endocrinology · 被引 98)
• Influence of proton pump inhibitors on microbiota in chronic liver disease patients (2019 · Hepatology International · 被引 51)
• Utility and limitations of noninvasive fibrosis markers for predicting prognosis in biopsy‐proven Japanese non‐alcoholic fatty liver disease patients (2018 · Journal of Gastroenterology and Hepatology · 被引 41)
• Tag‐less patency capsule for suspected small bowel stenosis: Nationwide multicenter prospective study in Japan (2020 · Digestive Endoscopy · 被引 35)
• Preoperative endoscopic predictors of severe submucosal fibrosis in colorectal tumors undergoing endoscopic submucosal dissection (2019 · Endoscopy International Open · 被引 33)